Literature DB >> 11302403

Antidepressant prescribing to Hispanic and non-Hispanic white patients in primary care.

B L Sleath1, R H Rubin, S A Huston.   

Abstract

OBJECTIVE: To examine whether there was a difference in the prescribing of selective serotonin-reuptake inhibitors (SSRIs) and non-SSRI antidepressants to Hispanic and non-Hispanic white patients in primary care.
METHODS: Twenty-seven family practice and internal medicine resident physicians and 407 of their Hispanic and non-Hispanic white patients who were fluent in English or Spanish participated in the study The medical records of all patients were reviewed and information about patient diagnoses and antidepressant prescriptions was abstracted. Logistic regression was used to examine whether Hispanic ethnicity influenced physician prescribing of SSRI and non-SSRI antidepressants while controlling for other patient characteristics and diagnoses. For patients with a diagnosis of depression, logistic regression was used to examine whether Hispanic ethnicity influenced whether patients received antidepressant treatment while controlling for other patient characteristics
RESULTS: Twenty-seven percent of patients received a prescription for one or more antidepressants. Hispanic and non-Hispanic white patients were equally likely to be prescribed SSRI and non-SSRI antidepressant medications. Having a diagnosis of depression and having a diagnosis of chronic pain was significantly correlated with the prescribing of a non-SSRI antidepressant (p < 0.001, p < 0.01, respectively). Having a diagnosis of depression was significantly correlated with the prescribing of an SSRI antidepressant (p < 0.001). Hispanic and non-Hispanic white patients with a diagnosis of depression were equally likely to be prescribed antidepressant treatment. Patients with a diagnosis of depression in the general medicine clinic were significantly less likely to receive antidepressant therapy than patients in the family practice clinic.
CONCLUSIONS: Hispanic ethnicity did not influence antidepressant prescribing. Future research in other settings is needed to further determine whether Hispanic ethnicity influences antidepressant prescribing.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302403     DOI: 10.1345/aph.10245

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  7 in total

Review 1.  Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review.

Authors:  Toshi A Furukawa; Hugh McGuire; Corrado Barbui
Journal:  BMJ       Date:  2002-11-02

Review 2.  Racial disparities in diagnosis and treatment of depression: a literature review.

Authors:  Sherri M Simpson; Laura L Krishnan; Mark E Kunik; Pedro Ruiz
Journal:  Psychiatr Q       Date:  2007-03

3.  Psychiatric treatment in primary care patients with anxiety disorders: a comparison of care received from primary care providers and psychiatrists.

Authors:  Risa B Weisberg; Ingrid Dyck; Larry Culpepper; Martin B Keller
Journal:  Am J Psychiatry       Date:  2007-02       Impact factor: 18.112

4.  Racial and ethnic disparities in the use of mental health services.

Authors:  Aram Dobalian; Patrick A Rivers
Journal:  J Behav Health Serv Res       Date:  2007-12-12       Impact factor: 1.505

5.  Depression and glycemic control in Hispanic primary care patients with diabetes.

Authors:  Raz Gross; Mark Olfson; Marc J Gameroff; Olveen Carasquillo; Steven Shea; Adriana Feder; Rafael Lantigua; Milton Fuentes; Myrna M Weissman
Journal:  J Gen Intern Med       Date:  2005-05       Impact factor: 5.128

6.  Blended care vs. usual care in the treatment of depressive symptoms and disorders in general practice [BLENDING]: study protocol of a non-inferiority randomized trial.

Authors:  Btissame Massoudi; Marco H Blanker; Evelien van Valen; Hans Wouters; Claudi L H Bockting; Huibert Burger
Journal:  BMC Psychiatry       Date:  2017-06-13       Impact factor: 3.630

7.  Guidelines on treatment of perinatal depression with antidepressants: An international review.

Authors:  Nina M Molenaar; Astrid M Kamperman; Philip Boyce; Veerle Bergink
Journal:  Aust N Z J Psychiatry       Date:  2018-03-05       Impact factor: 5.744

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.